The International Tennis Federation (ITF) has banned former Russian World No. 1 tennis player Maria Sharapova for two years over doping charges
The ban was imposed on her Independent Tribunal of ITF appointed under Tennis Anti-Doping Programme found that she had committed an Anti-Doping Rule Violation. It will commence on 26 January 2016.
In January 2016 during the Australian Open she was tested positive for banned drug meldonium, a substance that has been added in the forbidden list by the World Anti-Doping Agency (WADA) on 1 January 2016. Since then she was provisionally banned.
So far in her career, Maria Sharapova has won total 35 singles titles and five Grand Slam titles, two at the French Open and one each title at the Australian Open, Wimbledon, and US Open.
Meldonium: It is a medical drug (also known as Mildronate) given to patients suffering from heart and circulatory conditions for enhancing their physical capacity and mental function. Its use mainly leads to production more red blood cells (RBCs) in the body in order to increase oxygen supply to muscles for enhancing endurance.